Scout Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $26.1M | Buy |
|
|||||
|
2024
Q1 | $15.1M | Sell |
|
|||||
|
2023
Q4 | $34.5M | Sell |
|
|||||
|
2023
Q3 | $40.9M | Buy |
|
|||||
|
2023
Q2 | $35.3M | Buy |
|
|||||
|
2023
Q1 | $13.2M | Sell |
|
|||||
|
2022
Q4 | $19M | Sell |
|
|||||
|
2022
Q3 | $24.7M | Sell |
|
|||||
|
2022
Q2 | $23.6M | Hold |
|
|||||
|
2022
Q1 | $22.7M | Sell |
|
|||||
|
2021
Q4 | $21.2M | Sell |
|
|||||
|
2021
Q3 | $24.4M | Sell |
|
|||||
|
2021
Q2 | $25.2M | Buy |
|
|||||
|
2021
Q1 | $19.7M | Sell |
|
|||||
|
2020
Q4 | $22.3M | Sell |
|
|||||
|
2020
Q3 | $22.6M | Buy |
|
|||||
|
2020
Q2 | $21.2M | Buy |
|